Last reviewed · How we verify
ChiRhoStim
ChiRhoStim is a secretin receptor agonist that stimulates pancreatic secretion and gastrointestinal motility.
ChiRhoStim is a secretin receptor agonist that stimulates pancreatic secretion and gastrointestinal motility. Used for Pancreatic exocrine insufficiency.
At a glance
| Generic name | ChiRhoStim |
|---|---|
| Sponsor | ChiRhoClin, Inc. |
| Drug class | Secretin receptor agonist |
| Target | Secretin receptor |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Mechanism of action
The drug activates secretin receptors on pancreatic acinar cells and gastrointestinal smooth muscle, enhancing pancreatic enzyme and bicarbonate secretion while improving gastric and intestinal motility. This mechanism supports digestive function and may improve nutrient absorption in patients with pancreatic insufficiency or motility disorders.
Approved indications
- Pancreatic exocrine insufficiency
Common side effects
- Abdominal pain
- Nausea
- Diarrhea
Key clinical trials
- The Cancer of the Pancreas Screening-5 CAPS5)Study (PHASE3)
- Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency (PHASE3)
- Optical and Biochemical Biomarkers in Early Pancreatic Cancer
- MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics (NA)
- Effect of Secretin in Functional Dyspepsia and Healthy Subjects (PHASE1, PHASE2)
- Secretin for Acute Pancreatitis (PHASE2)
- Secretin Infusion for Pain Due to Chronic Pancreatitis (PHASE1, PHASE2)
- Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ChiRhoStim CI brief — competitive landscape report
- ChiRhoStim updates RSS · CI watch RSS
- ChiRhoClin, Inc. portfolio CI